BRIEF — EMA Concludes Review Of Ipidacrine — Containing Medicines
Sept 18 (Reuters) — EMA: Ema- Concludes Review Of Ipidacrine-containing Medicines, Recommended Restricting And Better Defining Approved Uses Ema: Ipidacrine No Longer Approved For Neuritis, Polyneuritis, Polyradiculoneuropathy, Myasthenic Syndrome Ema- Chmp Recommended Revising Approved Uses Of Ipidacrine To Align Them